Open the mobile version, with barcode scanning
Class I Ongoing

Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.

Why: Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Company
SoloVital
Chula Vista, CA, United States
Reported
Aug 7, 2024
Recall started
Jul 12, 2024
Where sold
Nationwide within the United States
Amount
1,331 bottles
Full product description
Umary Acido Hialuronico, Suplemento Alimenticio, 850 mg caplets, packaged in 30-count bottles.
Lots / codes affected
All lots within Expiry

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.